Literature DB >> 6614395

Ferrokinetic and hematologic studies in cystic fibrosis patients.

J S Wagener, G C McNeill, L M Taussig, J J Corrigan, R Lemen.   

Abstract

We investigated 28 cystic fibrosis (CF) patients to determine why hypoxia from their obstructive pulmonary disease does not produce polycythemia. Oxygen saturation was lower and erythropoietin levels were higher in CF patients than in 25 age-comparable reference subjects (90.8% and 47 mimu vs. 94.7% and 29 mimu, p less than 0.01). Hematocrit and red blood cell (RBC) indices were not different between groups. Serum vitamin and iron levels, ferrokinetics, RBC volume, and RBC survival were studied in 10 of the 28 CF patients. Total iron-binding capacity and vitamin E levels were low, and serum iron, ferritin, vitamin B12, and folate levels were normal in these patients. Red blood cell survival was minimally decreased in six patients although there was no other evidence for hemolysis. Ferrokinetics (59Fe) indicated a reduction in total erythropoiesis in only two patients. Plasma volume was high-normal in five and above normal in four CF patients; RBC mass was increased appropriately for each patient's degree of hypoxia, when compared to healthy individuals living at different altitudes. These results suggest that CF patients are able to compensate for hypoxia by increasing RBC mass; however, an expanded plasma volume prevents a detectable rise in hematocrit.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614395

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  6 in total

1.  Routine OGTT screening for CFRD - no thanks.

Authors:  Martin Walshaw
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

2.  Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis.

Authors:  Christine L Chan; Emma Hope; Jessica Thurston; Timothy Vigers; Laura Pyle; Philip S Zeitler; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2018-04-19       Impact factor: 19.112

3.  Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.

Authors:  Kevin J Scully; Jordan S Sherwood; Kimberly Martin; Melanie Ruazol; Peter Marchetti; Mary Larkin; Hui Zheng; Gregory S Sawicki; Ahmet Uluer; Isabel Neuringer; Lael M Yonker; Leonard Sicilian; Deborah J Wexler; Melissa S Putman
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 4.  Cystic fibrosis related diabetes.

Authors:  Donal O'Shea; Jean O'Connell
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

5.  Hemoglobin oxygen affinity in patients with cystic fibrosis.

Authors:  Dieter Böning; Angela Littschwager; Matthias Hütler; Ralph Beneke; Doris Staab
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

Review 6.  A Practical Approach to Glucose Abnormalities in Cystic Fibrosis.

Authors:  Gregory C Jones; Christopher A R Sainsbury
Journal:  Diabetes Ther       Date:  2016-10-17       Impact factor: 2.945

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.